Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer

We evaluated the survival benefit, safety, feasibility, and tolerability of dose-dense (DD) adjuvant chemotherapy with epirubicin and paclitaxel for women with node-positive primary breast cancer. Randomised patients (n=216) received DD or conventional-schedule (CS) chemotherapy. Dose-dense regimen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kümmel, S, Krocker, J, Kohls, A, Breitbach, G-P, Morack, G, Budner, M, Blohmer, J-U, Elling, D
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2006
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361407/
https://ncbi.nlm.nih.gov/pubmed/16622463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603085
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados